CRL-40,941
From Wikipedia, the free encyclopedia
|
|
|
| Systematic (IUPAC) name | |
|---|---|
|
2-{[Bis(4-fluorophenyl)methyl]sulfinyl}-N-hydroxyacetamide
|
|
| Clinical data | |
| Routes of administration |
Oral |
| Legal status |
|
| Identifiers | |
| CAS Number | 90212-80-9 |
| ATC code | none |
| PubChem | CID 13316557 |
| ChemSpider | 29785194 |
| Synonyms | Fluorafinil, Fladrafinil |
| Chemical data | |
| Formula | C15H13F2NO3S |
| Molar mass | 325.33 g/mol |
|
|
|
|
| |
|
CRL-40,941 is a wakefulness-promoting agent closely related to adrafinil and modafinil. It is the bis(p-fluoro) ring-substituted derivative of adrafinil. CRL-40,941 was found to produce antiaggressive effects in animals, which adrafinil does not produce.[1]
See also[edit]
References[edit]
- ^ US patent 4489095, Lafon, L., "Halogenobenzhydrylsulfinylacetohydroxamic Acids", issued 1984-12-18, assigned to Laboratoire L. Lafon
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |